(Q40116422)

17 September 2017

Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats (English)

1 reference

17 September 2017

0 references

1 reference

Nicholas M Wallingford

object named as

Nicholas M Wallingford

1

0 references

Puspha Sinnayah

object named as

Puspha Sinnayah

2

0 references

Michael Cowley

object named as

Michael A Cowley

9

0 references

author name string

Frank P Bymaster

3

1 reference

17 September 2017

Kishore M Gadde

4

1 reference

17 September 2017

Ranga K Krishnan

5

1 reference

17 September 2017

Anthony A McKinney

6

1 reference

17 September 2017

Ronald P Landbloom

7

1 reference

17 September 2017

Gary D Tollefson

8

1 reference

17 September 2017

language of work or name

English

0 references

publication date

5 March 2008

1 reference

17 September 2017

Neuropsychopharmacology

1 reference

17 September 2017

33

1 reference

17 September 2017

12

1 reference

17 September 2017

2922-2933

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2008.9

17 September 2017

0 references

cites work

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Naturalistic impact of second-generation antipsychotics on weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Protein distribution of the orexin-2 receptor in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

A parametric analysis of olanzapine-induced weight gain in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Antipsychotic drug-induced weight gain: development of an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Characterization of subpopulations of neurons producing melanin-concentrating hormone in the rat ventral diencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Mechanisms of action of antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Zonisamide for weight loss in obese adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Arousal and reward: a dichotomy in orexin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

A role for lateral hypothalamic orexin neurons in reward seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Overlapping and interactive pathways regulating appetite and craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

GABA receptor subtype antagonists in the nucleus accumbens shell and ventral tegmental area differentially alter feeding responses induced by deprivation, glucoprivation and lipoprivation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

A model for antipsychotic-induced obesity in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: A 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Effects of olanzapine on regional C-Fos expression in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Orexin: a link between energy homeostasis and adaptive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Diabetes, obesity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

The safety and tolerability of atypical antipsychotics in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Body mass index and quality of life in community-dwelling patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Safety and tolerability: how do newer generation "atypical" antipsychotics compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Dopamine receptor subtype agonists and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Drug-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Zonisamide and renal calculi in patients with epilepsy: how big an issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Characterization of olanzapine-induced weight gain in rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Effects of zonisamide on dopaminergic system

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Possible role of carbonic anhydrase in rat pancreatic islets: enzymatic, secretory, metabolic, ionic, and electrical aspects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.9

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.9

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference